These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21709377)

  • 41. Modelling the cost-effectiveness of impact-absorbing flooring in Swedish residential care facilities.
    Ryen L; Svensson M
    Eur J Public Health; 2016 Jun; 26(3):407-11. PubMed ID: 26498954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk.
    Smith L; Atherly A; Campbell J; Flattery N; Coronel S; Krantz M
    BMC Public Health; 2019 Sep; 19(1):1234. PubMed ID: 31492118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Impact of Including Costs and Outcomes of Dementia in a Health Economic Model to Evaluate Lifestyle Interventions to Prevent Diabetes and Cardiovascular Disease.
    Breeze P; Thomas C; Thokala P; Lafortune L; Brayne C; Brennan A
    Med Decis Making; 2020 Oct; 40(7):912-923. PubMed ID: 32951510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cost-effectiveness model of a community-based service for dementia caregivers].
    Dietl M; Kornhuber J; Schöffski O; Grässel E
    Gesundheitswesen; 2010 Feb; 72(2):99-105. PubMed ID: 19551624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden.
    Eklund O; Afzal F; Borgström F
    Cost Eff Resour Alloc; 2015; 13():13. PubMed ID: 26288574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cost-effectiveness of grip on challenging behaviour: an economic evaluation of a care programme for managing challenging behaviour.
    Zwijsen SA; Bosmans JE; Gerritsen DL; Pot AM; Hertogh CM; Smalbrugge M
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):567-74. PubMed ID: 26420646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.
    Lim G; Melnyk V; Facco FL; Waters JH; Smith KJ
    Anesthesiology; 2018 Feb; 128(2):328-337. PubMed ID: 29194062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Cost-Effectiveness of the Kiva Antibullying Program: Results from a Decision-Analytic Model.
    Persson M; Wennberg L; Beckman L; Salmivalli C; Svensson M
    Prev Sci; 2018 Aug; 19(6):728-737. PubMed ID: 29728796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Markov modeling for the neurosurgeon: a review of the literature and an introduction to cost-effectiveness research.
    Wali AR; Brandel MG; Santiago-Dieppa DR; Rennert RC; Steinberg JA; Hirshman BR; Murphy JD; Khalessi AA
    Neurosurg Focus; 2018 May; 44(5):E20. PubMed ID: 29712528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice.
    Lindgren P; Fahlstadius P; Hellenius ML; Jönsson B; de Faire U
    Prev Med; 2003 Apr; 36(4):403-9. PubMed ID: 12649048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program.
    Wimo A; Handels R; Antikainen R; Eriksdotter M; Jönsson L; Knapp M; Kulmala J; Laatikainen T; Lehtisalo J; Peltonen M; Sköldunger A; Soininen H; Solomon A; Strandberg T; Tuomilehto J; Ngandu T; Kivipelto M
    Alzheimers Dement; 2023 Mar; 19(3):999-1008. PubMed ID: 35841619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Probabilistic Markov models in economic evaluation of health technologies: a practical guide].
    Mar J; Antoñanzas F; Pradas R; Arrospide A
    Gac Sanit; 2010; 24(3):209-14. PubMed ID: 20409616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transitions between care settings in dementia: are they relevant in economic terms?
    Lueke S; Hoffmann W; Fleβa S
    Value Health; 2014 Sep; 17(6):679-85. PubMed ID: 25236991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of an in-home respite care program to support informal caregivers of persons with dementia: A model-based analysis.
    Vandepitte S; Putman K; Van Den Noortgate N; Verhaeghe N; Annemans L
    Int J Geriatr Psychiatry; 2020 Jun; 35(6):601-609. PubMed ID: 32011773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making.
    Ssegonja R; Sampaio F; Alaie I; Philipson A; Hagberg L; Murray K; Sarkadi A; Langenskiöld S; Jonsson U; Feldman I
    J Affect Disord; 2020 Dec; 277():789-799. PubMed ID: 33065819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An economic model of advance care planning in Australia: a cost-effective way to respect patient choice.
    Nguyen KH; Sellars M; Agar M; Kurrle S; Kelly A; Comans T
    BMC Health Serv Res; 2017 Dec; 17(1):797. PubMed ID: 29191183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'.
    De Smedt D; De Cocker K; Annemans L; De Bourdeaudhuij I; Cardon G
    Public Health Nutr; 2012 Mar; 15(3):442-51. PubMed ID: 21859505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial.
    Michalowsky B; Xie F; Eichler T; Hertel J; Kaczynski A; Kilimann I; Teipel S; Wucherer D; Zwingmann I; Thyrian JR; Hoffmann W
    Alzheimers Dement; 2019 Oct; 15(10):1296-1308. PubMed ID: 31409541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Costs of Inpatient Rehabilitation for Ischemic Stroke in Patients with Dementia: A Cohort Swedish Register-Based Study.
    Hoang MT; Kåreholt I; von Euler M; Jönsson L; von Koch L; Eriksdotter M; Garcia-Ptacek S
    J Alzheimers Dis; 2020; 73(3):967-979. PubMed ID: 31884465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cost utility of pitolisant as narcolepsy treatment.
    Bolin K; Niska PÅ; Pirhonen L; Wasling P; Landtblom AM
    Acta Neurol Scand; 2020 Apr; 141(4):301-310. PubMed ID: 31838740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.